Does FOSAPREPITANT DIMEGLUMINE Cause Therapy non-responder? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Therapy non-responder have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 2.6% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
23
Reports of Therapy non-responder with FOSAPREPITANT DIMEGLUMINE
2.6%
of all FOSAPREPITANT DIMEGLUMINE reports
20
Deaths
22
Hospitalizations
How Dangerous Is Therapy non-responder From FOSAPREPITANT DIMEGLUMINE?
Of the 23 reports, 20 (87.0%) resulted in death, 22 (95.7%) required hospitalization, and 23 (100.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Therapy non-responder Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL